KennethJamesTackMDFIDSA

PubMed

• 52 citations
  Pharmacokinetics and Safety of Single and Multiple Doses of ACHN-490 Injection Administered Intravenously in Healthy Subjects
  Robert T. Cass, Carter D. Brooks, Nancy A. Havrilla, Kenneth J. Tack, Marie T. Borin, Don Young, Jon B. Bruss> ;Antimicrobial Agents and Chemotherapy. 2011 Dec 1
• 1 citations
  Combined Retrospective Analysis of Seven Phase II and III Trials of the Efficacy of Linezolid in the Treatment of Pneumonia Caused by Multidrug-Resistant Streptococcus...
  M. Marian Ijzerman, Kenneth J. Tack, David B. Huang> ;Clinical Therapeutics. 2010 Dec 1
• 167 citations
  Complicated Skin and Skin-Structure Infections and Catheter-Related Bloodstream Infections: Noninferiority of Linezolid in a Phase 3 Study
  Mark H. Wilcox, Kenneth J. Tack, Emilio Bouza, Daniel Herr, Bernhard R. Ruf, M. Marian Ijzerman, Rodney V. Croos-Dabrera, Mark J. Kunkel, Charles Knirsch> ;Clinical Infectious Diseases. 2009 Jan 15
• 115 citations
  Efficacy and Safety of Linezolid Compared with Vancomycin in a Randomized, Double-Blind Study of Febrile Neutropenic Patients with Cancer
  Branimir Jakšić, Giovanni Martinelli, Jaime Perez-Oteyza, Charlotte S. Hartman, Linda B. Leonard, Kenneth J. Tack> ;Clinical Infectious Diseases. 2006 Mar 1
• 8 citations
  Clinafloxacin for the treatment of bacterial endocarditis.
  Donald P. Levine, H. Preston Holley, Irene A. Eiseman, P A Willcox, Kenneth J. Tack> ;Clinical Infectious Diseases. 2004 Mar 1
• 34 citations
  Randomized, Double-Blind, Multicenter Trial Comparing Clinafloxacin with Imipenem as Empirical Monotherapy for Febrile Granulocytopenic Patients
  Drew J. Winston, Hillard M. Lazarus, Roy A. Beveridge, James W. Hathorn, Rasim Gucalp, Reuben Ramphal, Anthony W. Chow, Winston G. Ho, Ruth Horn, Ronald Feld, Thomas J...> ;Clinical Infectious Diseases. 2001 Feb 1
• 47 citations
  Clinafloxacin versus Piperacillin-Tazobactam in Treatment of Patients with Severe Skin and Soft Tissue Infections
  G. Siami, N. Christou, I. Eiseman, Kenneth J. Tack> ;Antimicrobial Agents and Chemotherapy. 2001 Feb 1
• 42 citations
  Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections.
  Samuel E. Wilson, Nicholas V. Christou, Ori D. Rotstein, E. Patchen Dellinger, Robert S. Bennion, Raphael Pak, Kenneth J. Tack, Joseph S. Solomkin> ;Annals of Surgery. 2001 Jan 1
• 45 citations
  Comparative safety and efficacy of cefdinir vs amoxicillin/clavulanate for treatment of suppurative acute otitis media in children.
  Stan L. Block, James M. McCarty, James Hedrick, Mary Anne Nemeth, Constance H. Keyserling, Kenneth J. Tack> ;The Pediatric Infectious Disease Journal. 2000 Dec 1
• 17 citations
  Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection
  Alexander P. Leigh, Mary Anne Nemeth, Constance H. Keyserling, Leslie H. Hotary, Kenneth J. Tack> ;Clinical Therapeutics. 2000 Jul 1
• 18 citations
  Comparison of a 5 day regimen of cefdinir with a 10 day regimen of cefprozil for treatment of acute exacerbations of chronic bronchitis
  Charles M. Fogarty, Robert B. Bettis, Timothy J. Griffin, Constance H. Keyserling, Mary Anne Nemeth, Kenneth J. Tack> ;The Journal of Antimicrobial Chemotherapy. 2000 Jun 1
• 7 citations
  International study comparing cefdinir and cefuroxime axetil in the treatment of patients with acute exacerbation of chronic bronchitis.
  C.L.A. Van Herwaarden, Charles E. Langan, Gerhard Siemon, Claus Rudolph, Constance H. Keyserling, Mary Anne Nemeth, Kenneth J. Tack> ;International Journal of Infectious Diseases. 2000 Jan 1
• 18 citations
  Comparison of cefdinir and penicillin for the treatment of streptococcal pharyngitis
  Mary Anne Nemeth, James M. McCarty, W.M. Gooch, Dan C. Henry, Constance H. Keyserling, Kenneth J. Tack> ;Clinical Therapeutics. 1999 Nov 1
• 17 citations
  Comparison of cefdinir and penicillin for the treatment of pediatric streptococcal pharyngitis.
  Mary Anne Nemeth, W.M. Gooch, James Hedrick, Eric Slosberg, Constance H. Keyserling, Kenneth J. Tack> ;Clinical Therapeutics. 1999 Sep 1
• 32 citations
  Five-Day Cefdinir Treatment for Streptococcal Pharyngitis
  Kenneth J. Tack, Daniel C. Henry, W. Manford Gooch, Douglas N. Brink, Constance H. Keyserling> ;Antimicrobial Agents and Chemotherapy. 1998 May 1
• 34 citations
  Cefdinir versus cephalexin for the treatment of skin and skin-structure infections
  Kenneth J. Tack, Thomas W. Littlejohn, Gail B. Mailloux, Michelle M Wolf, Constance H. Keyserling> ;Clinical Therapeutics. 1998 Mar 1
• 15 citations
  Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia.
  Margaret Drehobl, Patrick Bianchi, Constance H. Keyserling, Kenneth J. Tack, Timothy J. Griffin> ;Antimicrobial Agents and Chemotherapy. 1997 Jul 1
• 29 citations
  Study of use of cefdinir versus cephalexin for treatment of skin infections in pediatric patients. The Cefdinir Pediatric Skin Infection Study Group.
  Kenneth J. Tack, Constance H. Keyserling, J McCarty, J A Hedrick> ;Antimicrobial Agents and Chemotherapy. 1997 Apr 1
• 5 citations
  Efficacy and Safety of Cefdinir in the Treatment of Patients with Acute Bronchitis
  Malcolm J Sperling, Anthony Puopolo, Timothy J. Griffin, Constance H. Keyserling, Kenneth J. Tack> ;Clinical Therapeutics. 1996 Jul 1
• 14 citations
  Initial clinical experience with clinafloxacin in the treatment of serious infections.
  Kenneth J. Tack, Nancy M. McGuire, Irene A. Eiseman> ;Drugs. 1995 Jan 1
• 18 citations
  Cefpodoxime Proxetil in the Treatment of Skin and Soft Tissue Infections
  Kenneth J. Tack, Nancy E. Wilks, Gregory Semerdjian, Calvin H. Frazier, Kim Shirin, Anthony Puopolo, Stanley G. Crossland, Bernard S. Goffe, Larry Millikan> ;Drugs. 1991 Jan 1
• 53 citations
  Effects of magnesium-aluminum hydroxide and calcium carbonate antacids on bioavailability of ofloxacin.
  Soledad Flor, David R.P. Guay, John A. Opsahl, Kenneth J. Tack, Gary R. Matzke> ;Antimicrobial Agents and Chemotherapy. 1990 Dec 1
• A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis.
  Paster, R. Z., McAdoo, M. A., Keyserling, C. H., Nemeth, M. A., Tack, K. J., Griffin, T. J.> ;Int J Clin Pract. 2000 Jun
• Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment.
  Flor, S., Guay, D., Opsahl, J., Tack, K., Matzke, G.> ;Int J Clin Pharmacol Res. 1991
• Inhibition of theophylline clearance by coadministered ofloxacin without alteration of theophylline effects.
  Gregoire, S. L., Grasela, T. H., Freer, J. P., Tack, K. J., Schentag, J. J.> ;Antimicrob Agents Chemother. 1987 Mar
• Join now to see all